Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A G Schmidt

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Das Osterreichische Zahntechniker Handwerk|April 1, 1970
[Inframass and hand-measurement appliances--2 new devices for manufacturing partial plastic prostheses]A G Schmidt
Deutsche Medizinische Wochenschrift (1946)|May 6, 2005
[Diastolic heart failure -- diagnostics]A G Schmidt, B Pieske
Deutsche Medizinische Wochenschrift (1946)|May 6, 2005
[Diastolic heart failure -- case report]A G Schmidt, B Pieske
Deutsche Medizinische Wochenschrift (1946)|May 6, 2005
[Diastolic heart failure -- therapy]A G Schmidt, B Pieske
Cardiovascular Drugs and Therapy|February 22, 2002
Phospholamban: a promising therapeutic target in heart failure?A G Schmidt, I Edes, E G Kranias
Archives of Orthopaedic and Trauma Surgery|January 1, 1994
Solitary skeletal lesions as primary manifestations of non-Hodgkin's lymphoma. Report of two cases and review of the literatureA G Schmidt, D Kohn, J Bernhards, et al.
The Journal of Biological Chemistry|April 15, 2000
Maximal inhibition of SERCA2 Ca(2+) affinity by phospholamban in transgenic hearts overexpressing a non-phosphorylatable form of phospholambanA G Brittsan, A N Carr, A G Schmidt, et al.
Clinical Pharmacology and Therapeutics|August 8, 1998
Disposition and immunodynamics of basiliximab in liver allograft recipientsJ Kovarik, T Breidenbach, C Gerbeau, et al.
Journal of Molecular and Cellular Cardiology|September 11, 2001
Letter to the editor: Re-evaluation of heart failure in transgenic mice with impaired SR Ca2+ releaseY Sato, A G Schmidt, H Kiriazis, et al.
Lancet (London, England)|July 4, 1998
Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study GroupB Nashan, R Moore, P Amlot, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Das Osterreichische Zahntechniker Handwerk|April 1, 1970
[Inframass and hand-measurement appliances--2 new devices for manufacturing partial plastic prostheses]A G Schmidt
Deutsche Medizinische Wochenschrift (1946)|May 6, 2005
[Diastolic heart failure -- diagnostics]A G Schmidt, B Pieske
Deutsche Medizinische Wochenschrift (1946)|May 6, 2005
[Diastolic heart failure -- case report]A G Schmidt, B Pieske
Deutsche Medizinische Wochenschrift (1946)|May 6, 2005
[Diastolic heart failure -- therapy]A G Schmidt, B Pieske
Cardiovascular Drugs and Therapy|February 22, 2002
Phospholamban: a promising therapeutic target in heart failure?A G Schmidt, I Edes, E G Kranias
Archives of Orthopaedic and Trauma Surgery|January 1, 1994
Solitary skeletal lesions as primary manifestations of non-Hodgkin's lymphoma. Report of two cases and review of the literatureA G Schmidt, D Kohn, J Bernhards, et al.
The Journal of Biological Chemistry|April 15, 2000
Maximal inhibition of SERCA2 Ca(2+) affinity by phospholamban in transgenic hearts overexpressing a non-phosphorylatable form of phospholambanA G Brittsan, A N Carr, A G Schmidt, et al.
Clinical Pharmacology and Therapeutics|August 8, 1998
Disposition and immunodynamics of basiliximab in liver allograft recipientsJ Kovarik, T Breidenbach, C Gerbeau, et al.
Journal of Molecular and Cellular Cardiology|September 11, 2001
Letter to the editor: Re-evaluation of heart failure in transgenic mice with impaired SR Ca2+ releaseY Sato, A G Schmidt, H Kiriazis, et al.
Lancet (London, England)|July 4, 1998
Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study GroupB Nashan, R Moore, P Amlot, et al.
Pageof 3